(Press-News.org) LOS ANGELES (Oct. 9, 2012) – Approximately 14 percent of individuals suffering from depression and other mental health issues in the United States are minorities in underserved communities, yet very few medications or psychosocial interventions have been developed utilizing the participation of these groups. This year, Bowen Chung, M.D. - principal investigator at The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) - will change that when two unique studies are initiated: the first study will utilize intervention that focuses on families to improve outcomes for psychotic and bipolar adolescents and young adults, while the second study will evaluate the benefit of classes that teach skills to improve mood and resiliency in the face of daily stresses.
Working with lead investigator David Miklowitz, Ph.D., Professor of Psychiatry at UCLA School of Medicine, and funded by a two-year, $300,000 grant from the National Institutes of Mental Health (NIMH), Dr. Chung's first project involves family-focused therapy. Family-focused therapy has been in development and tested for nearly 20 years, yet much of the research has been conducted in an academic setting. Testing this approach for the first time in a community setting, Drs. Chung and Miklowitz will be working to train clinicians at county agencies in the Los Angeles area. The study seeks to determine if increased training for clinicians will impact how treatment is delivered, and if family therapy treatment will be effective on the patients.
Family-focused therapy is evidence-based therapy that has been shown to improve outcomes for bipolar and psychotic youth by improving adherence to medication and decreasing the likelihood of depression, which is a major problem for young adults with bipolar disorder.
"What's unique and exciting about this therapy is that it involves the entire family rather than just the individual," said Dr. Chung. "It focuses on improving sleep patterns, recognizing impending episodes, problem-solving skills, and increased communication between family members to help improve outcomes."
For the second study, Dr. Chung and his colleagues have partnered with local social service agencies, churches, and health advocacy organizations to train non-mental health professionals to deliver a resiliency class. Entitled "Building Resiliency and Community Hope," the study helps to provide individuals suffering from depression with the necessary skills to improve mood, and enhance the ability to bounce back from the stresses of daily living in urban Los Angeles.
The study – developed in conjunction with UCLA and supported by the California Community Foundation and UCLA Clinical and Translational Science Institute's offices at LA BioMed/Harbor-UCLA - includes a six-session class based on cognitive-behavioral therapy principles and will be delivered by non-professionals. This class was developed by the community and academic partners of another NIMH-funded study, Community Partners in Care.
The impetus for this project was the need for psychosocial intervention to enhance mood in neighborhoods such as South Los Angeles where access to health care and mental health services is limited. The two lead community organizations, Healthy African American Families II and the First African Presbyterian Church, will partner with Dr. Chung during all steps of the research process to ensure that the study aligns with the needs and priorities of residents in the Centinela Valley in South Los Angeles.
The pilot study will begin this fall and involve approximately 20 people, while the second phase will be a randomized trial that begins in winter 2013.
###
About LA BioMed
Founded in 1952, LA BioMed is one of the country's leading nonprofit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into improved treatments and cures for cancer, inherited diseases, infectious diseases, illnesses caused by environmental factors and more. It also educates young scientists and provides community services, including prenatal counseling and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit www.LABioMed.org.
LA BioMed's Dr. Bowen Chung delivering mental health care to troubled youths and adolescents
2012-10-09
ELSE PRESS RELEASES FROM THIS DATE:
Secondary osteoporosis: More than what meets the eye!
2012-10-09
An SGH study has revealed that considering all osteoporotic patients as having simple osteoporosis and treating all of them alike by putting them on potent long term medication without finding out the cause of their osteoporosis may be ineffective and in most cases downright harmful.
Secondary osteoporosis is a rather common but lesser known type of osteoporosis that affects men and women of any age. It is caused by certain medical conditions that result in bone loss or interfere with development of peak bone mass. Contributors of secondary osteoporosis include conditions ...
Coffee speeds up return of bowel function after colon surgery
2012-10-09
Patients who drank coffee, rather than water, after bowel surgery to remove a part of their colon experienced a quicker return to bowel movements and tolerance of solid food.
Those are two of the key findings of a comparative study of 80 patients, carried out at University Hospital Heidelberg, Germany, and published in the surgical journal BJS.
"Post-operative bowel obstruction is a common problem after abdominal surgery and the aim of this study was to test our theory that coffee would help to alleviate this" says lead author Dr Sascha Müller, who is now based at ...
Glowing DNA invention points towards high speed disease detection
2012-10-09
Links to publications:
http://pubs.acs.org/doi/abs/10.1021/nn302633q
http://pubs.acs.org/doi/abs/10.1021/ac201903n
...
Mayo Clinic researchers stop neuromyelitis optica attacks with new therapy
2012-10-09
ROCHESTER, Minn. -- Mayo Clinic researchers have identified a new therapy for patients with neuromyelitis optica that appears to stop inflammation of the eye nerves and spinal cord. NMO is a debilitating central nervous system disorder that is often misdiagnosed as multiple sclerosis (MS). In the study, patients with severe symptoms of the disease, also known as NMO, were given eculizumab, a drug typically used to treat blood disorders.
While not a cure, the therapy Mayo Clinic researchers used in the study to halt attacks could potentially lead to longer attack-free ...
Dead stars could be the future of spacecraft navigation
2012-10-09
Scientists at the National Physical Laboratory (NPL) and the University of Leicester have been commissioned by the European Space Agency (ESA) to investigate the feasibility of using dead stars to navigate spacecraft in deep space. The findings of the research will advise ESA strategy and if feasible this technique may in future revolutionise the way spacecraft navigate in the outer Solar System and beyond.
Spacecraft navigation currently relies on radio transmissions between a distant craft and a network of ground-stations on Earth. This means that the craft has to ...
IspH -- a protein free to choose its partners
2012-10-09
This press release is available in German.
The iron-sulfur protein IspH plays a central role in the terpene metabolism of several pathogens. The mechanism of the reaction provides an approach for developing new antibiotics, particularly against malaria and tuberculosis. While researching this enzyme, biochemists at the Technische Universitat Munchen discovered a previously unknown reaction: IspH accepts two completely different classes of molecules as partners. This surprising insight, published in Nature Communications, opens up new perspectives in combating infectious ...
Scientists discover gene behind rare disorders
2012-10-09
Scientists at the Montreal Neurological Institute and Hospital – The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.
Using a new technique that has revolutionized genetic studies, the teams determined that mutations in the RMND1 gene were responsible for severe neurodegenerative disorders, in two infants, ultimately leading to their early death. Although the teams' investigations dealt with an infant, their discovery also has implications for understanding the causes of ...
Chaperone protein subverts removal of glaucoma-causing protein
2012-10-09
Tampa, FL (Oct. 8, 2012) -- The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.
Reported online this month in JBC (The Journal of Biological Chemistry), the discoveries could lead to a new treatment for some hereditary cases of glaucoma, an eye ...
Topological superconductors
2012-10-09
If quantum computers are ever going to perform all those expected feats of code-breaking and number crunching, then their component qubits---tiny ephemeral quantum cells held in a superposition of internal states---will have to be protected from intervention by the outside world. In other words, decoherence, the loss of the qubits' quantum integrity, has to be postponed. Now theoretical physicists at the Joint Quantum Institute (JQI) and the University of Maryland have done an important step forward to understand qubits in a real-world setup. In a new study they show, ...
Bioenergy - The broken promise
2012-10-09
Biofuels are going to save us from climate threats and the oil crisis, while at the same time providing an opportunity to the smallholder farmers of the world. Hopes are high, but completely unrealistic. It is like trying to push a square peg into a round hole, according to a current thesis at Linköping University.
Bioenergy could replace fossil fuels and solve the looming energy crisis. Into the bargain, we will benefit from reduced greenhouse gas emissions. A further bonus could be that demand for biofuels gives a lift to smallholder farmers in poor countries, who would ...